1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow MDGN-002: new trials by email Literature Review of MDGN-002 trials Research Report on MDGN-002
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis MDGN-002 - Crohn Disease, Ulcerative Colitis | Phase 1 | Terminated | Avalo Therapeutics, Inc. | 8 | 2017-07-14 | 2024-02-26 |
Colitis, Ulcerative (1) · Crohn Disease (1)
United States (1)